Supernus, Indivior Merge
Supernus and Indivior merge to create CNS biopharmaceutical leader
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
LNTH Curium Announces Definitive Agreement to Merge with Lantheus. Curium to acquire Lantheus for $102.50/share in cash, plus CVR for up to
LNTH Curium Announces Definitive Agreement to Merge with Lantheus. Curium to acquire Lantheus for $102.50/share in cash, plus CVR for up to $12/share